nodes	percent_of_prediction	percent_of_DWPC	metapath
Mupirocin—IARS—hair follicle—melanoma	0.109	0.279	CbGeAlD
Mupirocin—IARS—neck—melanoma	0.0733	0.187	CbGeAlD
Mupirocin—Wound infection—Temozolomide—melanoma	0.066	0.108	CcSEcCtD
Mupirocin—IARS—eye—melanoma	0.0546	0.139	CbGeAlD
Mupirocin—IARS—retina—melanoma	0.0541	0.138	CbGeAlD
Mupirocin—Rash generalised—Vemurafenib—melanoma	0.0499	0.0819	CcSEcCtD
Mupirocin—IARS—skin of body—melanoma	0.0475	0.121	CbGeAlD
Mupirocin—IARS—head—melanoma	0.031	0.0791	CbGeAlD
Mupirocin—Ulcerative stomatitis—Dactinomycin—melanoma	0.0259	0.0426	CcSEcCtD
Mupirocin—IARS—lymph node—melanoma	0.0217	0.0554	CbGeAlD
Mupirocin—Rash generalised—Docetaxel—melanoma	0.0169	0.0279	CcSEcCtD
Mupirocin—Tenderness—Bleomycin—melanoma	0.0147	0.0242	CcSEcCtD
Mupirocin—Dry skin—Vemurafenib—melanoma	0.0141	0.0232	CcSEcCtD
Mupirocin—Mouth ulceration—Dactinomycin—melanoma	0.0108	0.0178	CcSEcCtD
Mupirocin—Erythema—Vemurafenib—melanoma	0.00927	0.0152	CcSEcCtD
Mupirocin—Swelling—Carmustine—melanoma	0.00923	0.0152	CcSEcCtD
Mupirocin—Ear pain—Temozolomide—melanoma	0.00922	0.0151	CcSEcCtD
Mupirocin—Dysgeusia—Vemurafenib—melanoma	0.00908	0.0149	CcSEcCtD
Mupirocin—Dermatitis exfoliative—Temozolomide—melanoma	0.00834	0.0137	CcSEcCtD
Mupirocin—Cough—Vemurafenib—melanoma	0.00809	0.0133	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00784	0.0129	CcSEcCtD
Mupirocin—Anaphylactic shock—Vemurafenib—melanoma	0.00756	0.0124	CcSEcCtD
Mupirocin—Skin disorder—Vemurafenib—melanoma	0.00735	0.0121	CcSEcCtD
Mupirocin—Dry skin—Temozolomide—melanoma	0.00721	0.0118	CcSEcCtD
Mupirocin—Haemoglobin—Bleomycin—melanoma	0.00648	0.0107	CcSEcCtD
Mupirocin—Haemorrhage—Bleomycin—melanoma	0.00645	0.0106	CcSEcCtD
Mupirocin—Pharyngitis—Dactinomycin—melanoma	0.00597	0.00981	CcSEcCtD
Mupirocin—Swelling—Docetaxel—melanoma	0.00593	0.00974	CcSEcCtD
Mupirocin—Haemoglobin—Carmustine—melanoma	0.00566	0.0093	CcSEcCtD
Mupirocin—Haemorrhage—Carmustine—melanoma	0.00563	0.00925	CcSEcCtD
Mupirocin—Erythema—Bleomycin—melanoma	0.00561	0.00923	CcSEcCtD
Mupirocin—Hypersensitivity—Vemurafenib—melanoma	0.00557	0.00916	CcSEcCtD
Mupirocin—Haemoglobin—Temozolomide—melanoma	0.00547	0.00899	CcSEcCtD
Mupirocin—Haemorrhage—Temozolomide—melanoma	0.00544	0.00894	CcSEcCtD
Mupirocin—Pharyngitis—Temozolomide—melanoma	0.0054	0.00887	CcSEcCtD
Mupirocin—Pruritus—Vemurafenib—melanoma	0.00535	0.00879	CcSEcCtD
Mupirocin—Erythema—Dactinomycin—melanoma	0.00524	0.0086	CcSEcCtD
Mupirocin—Diarrhoea—Vemurafenib—melanoma	0.00518	0.0085	CcSEcCtD
Mupirocin—Dizziness—Vemurafenib—melanoma	0.005	0.00822	CcSEcCtD
Mupirocin—Immune system disorder—Temozolomide—melanoma	0.00491	0.00808	CcSEcCtD
Mupirocin—Erythema—Carmustine—melanoma	0.0049	0.00805	CcSEcCtD
Mupirocin—Cough—Bleomycin—melanoma	0.0049	0.00805	CcSEcCtD
Mupirocin—Dry skin—Docetaxel—melanoma	0.00479	0.00788	CcSEcCtD
Mupirocin—Rash—Vemurafenib—melanoma	0.00477	0.00784	CcSEcCtD
Mupirocin—Dermatitis—Vemurafenib—melanoma	0.00476	0.00783	CcSEcCtD
Mupirocin—Headache—Vemurafenib—melanoma	0.00474	0.00779	CcSEcCtD
Mupirocin—Erythema—Temozolomide—melanoma	0.00474	0.00778	CcSEcCtD
Mupirocin—Dysgeusia—Temozolomide—melanoma	0.00464	0.00762	CcSEcCtD
Mupirocin—Anaphylactic shock—Bleomycin—melanoma	0.00458	0.00753	CcSEcCtD
Mupirocin—Nausea—Vemurafenib—melanoma	0.00449	0.00738	CcSEcCtD
Mupirocin—Angioedema—Temozolomide—melanoma	0.00433	0.00711	CcSEcCtD
Mupirocin—Cough—Temozolomide—melanoma	0.00413	0.00679	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.004	0.00658	CcSEcCtD
Mupirocin—Dry mouth—Temozolomide—melanoma	0.00394	0.00648	CcSEcCtD
Mupirocin—Pain—Bleomycin—melanoma	0.00392	0.00644	CcSEcCtD
Mupirocin—Anaphylactic shock—Temozolomide—melanoma	0.00387	0.00635	CcSEcCtD
Mupirocin—Epistaxis—Docetaxel—melanoma	0.0038	0.00625	CcSEcCtD
Mupirocin—Skin disorder—Temozolomide—melanoma	0.00375	0.00617	CcSEcCtD
Mupirocin—Pain—Dactinomycin—melanoma	0.00365	0.00601	CcSEcCtD
Mupirocin—Urticaria—Bleomycin—melanoma	0.00364	0.00598	CcSEcCtD
Mupirocin—Haemoglobin—Docetaxel—melanoma	0.00364	0.00598	CcSEcCtD
Mupirocin—Rhinitis—Docetaxel—melanoma	0.00363	0.00596	CcSEcCtD
Mupirocin—Haemorrhage—Docetaxel—melanoma	0.00362	0.00595	CcSEcCtD
Mupirocin—Pharyngitis—Docetaxel—melanoma	0.00359	0.0059	CcSEcCtD
Mupirocin—Gastrointestinal pain—Dactinomycin—melanoma	0.00349	0.00574	CcSEcCtD
Mupirocin—Pain—Carmustine—melanoma	0.00342	0.00562	CcSEcCtD
Mupirocin—Abdominal pain—Dactinomycin—melanoma	0.00338	0.00555	CcSEcCtD
Mupirocin—Hypersensitivity—Bleomycin—melanoma	0.00338	0.00555	CcSEcCtD
Mupirocin—Pain—Temozolomide—melanoma	0.00331	0.00543	CcSEcCtD
Mupirocin—Gastrointestinal pain—Carmustine—melanoma	0.00327	0.00537	CcSEcCtD
Mupirocin—Immune system disorder—Docetaxel—melanoma	0.00327	0.00537	CcSEcCtD
Mupirocin—Pruritus—Bleomycin—melanoma	0.00324	0.00533	CcSEcCtD
Mupirocin—Abdominal pain—Carmustine—melanoma	0.00316	0.0052	CcSEcCtD
Mupirocin—Gastrointestinal pain—Temozolomide—melanoma	0.00316	0.00519	CcSEcCtD
Mupirocin—Erythema—Docetaxel—melanoma	0.00315	0.00518	CcSEcCtD
Mupirocin—Hypersensitivity—Dactinomycin—melanoma	0.00315	0.00517	CcSEcCtD
Mupirocin—Dysgeusia—Docetaxel—melanoma	0.00308	0.00507	CcSEcCtD
Mupirocin—Urticaria—Temozolomide—melanoma	0.00307	0.00505	CcSEcCtD
Mupirocin—Abdominal pain—Temozolomide—melanoma	0.00306	0.00502	CcSEcCtD
Mupirocin—Hypersensitivity—Carmustine—melanoma	0.00295	0.00484	CcSEcCtD
Mupirocin—Diarrhoea—Dactinomycin—melanoma	0.00292	0.00481	CcSEcCtD
Mupirocin—Rash—Bleomycin—melanoma	0.00289	0.00475	CcSEcCtD
Mupirocin—Dermatitis—Bleomycin—melanoma	0.00289	0.00474	CcSEcCtD
Mupirocin—Hypersensitivity—Temozolomide—melanoma	0.00285	0.00468	CcSEcCtD
Mupirocin—Cough—Docetaxel—melanoma	0.00275	0.00452	CcSEcCtD
Mupirocin—Diarrhoea—Carmustine—melanoma	0.00274	0.0045	CcSEcCtD
Mupirocin—Pruritus—Temozolomide—melanoma	0.00273	0.00449	CcSEcCtD
Mupirocin—Nausea—Bleomycin—melanoma	0.00272	0.00447	CcSEcCtD
Mupirocin—Rash—Dactinomycin—melanoma	0.00269	0.00443	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.00266	0.00438	CcSEcCtD
Mupirocin—Dizziness—Carmustine—melanoma	0.00265	0.00435	CcSEcCtD
Mupirocin—Diarrhoea—Temozolomide—melanoma	0.00264	0.00435	CcSEcCtD
Mupirocin—Dry mouth—Docetaxel—melanoma	0.00262	0.00431	CcSEcCtD
Mupirocin—Anaphylactic shock—Docetaxel—melanoma	0.00257	0.00422	CcSEcCtD
Mupirocin—Dizziness—Temozolomide—melanoma	0.00256	0.0042	CcSEcCtD
Mupirocin—Nausea—Dactinomycin—melanoma	0.00254	0.00417	CcSEcCtD
Mupirocin—Rash—Carmustine—melanoma	0.00252	0.00414	CcSEcCtD
Mupirocin—Dermatitis—Carmustine—melanoma	0.00252	0.00414	CcSEcCtD
Mupirocin—Headache—Carmustine—melanoma	0.00251	0.00412	CcSEcCtD
Mupirocin—Skin disorder—Docetaxel—melanoma	0.0025	0.0041	CcSEcCtD
Mupirocin—Rash—Temozolomide—melanoma	0.00244	0.004	CcSEcCtD
Mupirocin—Dermatitis—Temozolomide—melanoma	0.00244	0.004	CcSEcCtD
Mupirocin—Headache—Temozolomide—melanoma	0.00242	0.00398	CcSEcCtD
Mupirocin—Nausea—Carmustine—melanoma	0.00238	0.0039	CcSEcCtD
Mupirocin—Nausea—Temozolomide—melanoma	0.0023	0.00377	CcSEcCtD
Mupirocin—Pain—Docetaxel—melanoma	0.0022	0.00361	CcSEcCtD
Mupirocin—Gastrointestinal pain—Docetaxel—melanoma	0.0021	0.00345	CcSEcCtD
Mupirocin—Abdominal pain—Docetaxel—melanoma	0.00203	0.00334	CcSEcCtD
Mupirocin—Hypersensitivity—Docetaxel—melanoma	0.00189	0.00311	CcSEcCtD
Mupirocin—Pruritus—Docetaxel—melanoma	0.00182	0.00299	CcSEcCtD
Mupirocin—Diarrhoea—Docetaxel—melanoma	0.00176	0.00289	CcSEcCtD
Mupirocin—Dizziness—Docetaxel—melanoma	0.0017	0.00279	CcSEcCtD
Mupirocin—Rash—Docetaxel—melanoma	0.00162	0.00266	CcSEcCtD
Mupirocin—Dermatitis—Docetaxel—melanoma	0.00162	0.00266	CcSEcCtD
Mupirocin—Headache—Docetaxel—melanoma	0.00161	0.00265	CcSEcCtD
Mupirocin—Nausea—Docetaxel—melanoma	0.00153	0.00251	CcSEcCtD
